Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
September 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
Press releases published on August 26, 2025
NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
GlobeNewswire
·
August 26, 2025
EMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its Board of Directors and the Special Transaction Committee of the Board of Directors has declared a one-time …
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
GlobeNewswire
·
August 26, 2025
MENLO PARK, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …
SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025
GlobeNewswire
·
August 26, 2025
SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanley 23rd Annual …
Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
August 26, 2025
PURCHASE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, was notified by The Nasdaq Listing …
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 26, 2025
NEWTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease …
BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025
GlobeNewswire
·
August 26, 2025
NEW HAVEN, Conn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will host an investor …
Plus de 2 000 opérations chirurgicales effectuées avec succès dans des cas d’épilepsie pharmaco-résistante
GlobeNewswire
·
August 26, 2025
RIYAD, Arabie saoudite, 26 août 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital …
Mehr als 2.000 erfolgreiche Eingriffe bei medikamentenresistenter Epilepsie
GlobeNewswire
·
August 26, 2025
RIAD, Saudi-Arabien, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Das King Faisal Specialist Hospital …
Tevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company’s Mission of Health Equity
GlobeNewswire
·
August 26, 2025
WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today expressed its appreciation to Yale University for recognizing Founder and CEO Dr. Ryan Saadi, MPH ’95, and the Company’s mission of …
Oral Surgery Expert Dr. Yadira Cardona-Rohena Offers Advice on Tooth Extraction Prevention in HelloNation
GlobeNewswire
·
August 26, 2025
DACULA, Ga., Aug. 26, 2025 (GLOBE NEWSWIRE) -- What happens when poor dental hygiene is ignored for too long? According to Dr. Yadira Cardona-Rohena of Hamilton Mill Oral …
KFSHRC Saves Saudi 7-Year-Old Through Cross-Border Heart Transplant with UAE Donor
GlobeNewswire
·
August 26, 2025
RIYADH, Saudi Arabia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed a life-saving heart transplant on a 7-year-old Saudi child using an organ donated by a brain-dead …
PEMF Therapy Emerges as a Leading 2025 Wellness Trend for Drug-Free Pain Relief; Grooni Earthing’s Pro Collection Meets Rising Demand
GlobeNewswire
·
August 26, 2025
SHERIDAN, WY , Aug. 26, 2025 (GLOBE NEWSWIRE) -- As consumers seek science-informed, non-pharmacological options for chronic pain and recovery, pulsed electromagnetic field (PEMF) therapy is gaining momentum. Market analysis from Future Market Insights …
Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight
GlobeNewswire
·
August 26, 2025
New York, USA, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight The market for untreated metastatic or …
Global Bioanalytical Testing Services Market to Observe Stunning Growth at a CAGR of ~16% by 2032 | DelveInsight
GlobeNewswire
·
August 26, 2025
New York, USA, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Global Bioanalytical Testing Services Market to Observe Stunning Growth at a CAGR of ~16% by 2032 | DelveInsight The bioanalytical testing services market is witnessing substantial growth, primarily fueled …
Becker’s Healthcare Names U.S. Oral Surgery Management to 2025 DSOs to Know List
GlobeNewswire
·
August 26, 2025
IRVING, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) -- For the second year in a row, Becker’s Healthcare has named U.S. Oral Surgery Management (USOSM) to this year’s DSOs to Know list. Honorees are selected by Becker’s, based on nominations and reporter …
Trethera Awarded $2.3 Million NIH Grant to Study TRE-515 Combined with Radiation Therapy in Prostate Cancer Preclinical Models
GlobeNewswire
·
August 26, 2025
LOS ANGELES, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today the award of a new $2.3 million Small …
Advanced Fat Burners for Men & Women for belly Fat 2025: Wolfson Brands Launch “ Safest weight-loss supplement in USA.
GlobeNewswire
·
August 26, 2025
new York, Aug. 26, 2025 (GLOBE NEWSWIRE) -- New York, Aug. 22, 2025 Wolfson Brands has introduced an upgraded collection of fat-burning supplements. The leading health and wellness experts today unveiled their list of Best Fat Burners for Men and Women, …
University of St. Augustine for Health Sciences Sponsors U.S. Open Adaptive Surfing Championships for Fifth Consecutive Year
GlobeNewswire
·
August 26, 2025
OCEANSIDE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The University of St. Augustine for Health Sciences (USAHS) is proud to announce its continued role as the title sponsor for the 8th Annual U.S. Open Adaptive Surfing Championships, taking place …
Circurna Engages GATC Health for AI-Powered Discovery to Accelerate ciRNA™ Circular RNA Therapeutics
GlobeNewswire
·
August 26, 2025
HOUSTON and IRVINE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Circurna, (www.circurna.com) a biotechnology company advancing its proprietary ciRNA™ circular RNA platform, and GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) …
Patient-Led Decisions Accelerate IBD Treatment Switching, Spherix Global Insights Finds
GlobeNewswire
·
August 26, 2025
EXTON, PA, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Patients with inflammatory bowel disease (IBD) in the US are taking a more active role than ever before in the decision to switch their advanced therapies, driving faster transitions between treatments and …